Jul 7, 2025 09:48AM
Jun 24, 2025 03:50PM
Jun 16, 2025 07:28AM
Jun 13, 2025 04:06PM
Jun 13, 2025 04:05PM
Jun 5, 2025 07:00AM
Jun 3, 2025 04:01PM KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 2, 2025 07:00AM
May 29, 2025 07:00AM
May 22, 2025 07:00AM
May 2, 2025 07:00AM
Apr 30, 2025 07:00AM
Apr 23, 2025 04:20AM
Apr 8, 2025 06:31AM KalVista Pharmaceuticals (KALV) Enters Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
Apr 8, 2025 06:30AM
Apr 2, 2025 07:00AM
Mar 31, 2025 07:00AM
Mar 26, 2025 06:57AM
Mar 26, 2025 04:11AM
Mar 25, 2025 07:02AM
Mar 25, 2025 07:00AM KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial
Mar 17, 2025 06:41AM
Mar 13, 2025 04:36AM
Mar 12, 2025 07:00AM
Mar 10, 2025 07:00AM
Mar 4, 2025 07:00AM
Mar 3, 2025 07:05AM
Mar 3, 2025 07:00AM KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
Mar 3, 2025 04:46AM
Feb 24, 2025 07:00AM
Feb 21, 2025 07:00AM
Feb 10, 2025 07:00AM
Feb 4, 2025 07:00AM
Jan 21, 2025 07:01AM
Jan 21, 2025 07:00AM KalVista Announces Orphan Drug Designation and NDA Submission for Sebetralstat in Japan for Hereditary Angioedema
Jan 8, 2025 06:30AM
Dec 18, 2024 06:33AM
Dec 16, 2024 07:01AM
Dec 16, 2024 07:00AM
Dec 6, 2024 06:46AM
Dec 5, 2024 06:30AM
Dec 4, 2024 06:30AM KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 26, 2024 07:00AM
Nov 26, 2024 07:00AM
Nov 12, 2024 06:30AM
Nov 5, 2024 07:13AM
Nov 4, 2024 07:04AM
Nov 4, 2024 07:00AM
Oct 28, 2024 06:31AM KalVista Pharmaceuticals (KALV) Presents New Sebetralstat Data
Oct 28, 2024 06:30AM

15,422 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All